QualityStocksNewsBreaks Archives - Page 149 of 1424

ThursdayMay 09, 2024 10:38 am

QualityStocksNewsBreaks – CSP Inc. (NASDAQ: CSPI) Announces Operational Results for Fiscal Q2 2024, Quarterly Dividend

CSP (NASDAQ: CSPI), an award-winning provider of cybersecurity AI-driven solutions (“AZT”), security and packet capture products, managed IT and professional / cloud services and technology solutions, has announced results for the fiscal second quarter ended March 31, 2024. The company also announced that its board of directors declared a quarterly dividend of $0.03 per share payable June 12, 2024, to shareholders of record on the close of business on May 24, 2024. “Our business continued to operate at a high level during the quarter, and across the board we are building a pipeline that is in line with, or well…

WednesdayMay 08, 2024 3:30 pm

QualityStocksNewsBreaks – Bravo Multinational Inc. (BRVO) Is Pioneering Innovative Solutions in Digital Content Landscape

Bravo (OTC: BRVO) is a company actively exploring opportunities in the entertainment, hospitality and technology sectors to generate long-term value through high-growth business ventures. “Bravo is currently focused on pioneering innovative solutions in the digital content landscape, with a goal of providing cutting-edge and diverse content experiences to global audiences. In February 2024, Bravo finalized a deal to acquire Streaming TVEE Inc.’s assets, making a step toward establishing its flagship offering, TVee NOW(TM). The assets acquired from Streaming TVEE provide Bravo with the technology and foundation to offer streaming services, including video-on-demand (‘VOD’) and linear television – encompassing cable and…

WednesdayMay 08, 2024 3:10 pm

QualityStocksNewsBreaks – Correlate Energy Corp. (CIPI) Eyes Opportunities in Most Applicable Tech

Correlate (OTCQB: CIPI) is a distributed energy solutions company focused on solar energy installation opportunities as well as other clean energy infrastructure improvements. As federal government incentives and decreasing costs of solar installation help to scale clean energy adoption across the United States, CIPI is positioned for growth. “We have a constant conveyor belt of a maturity of opportunities which allow us to smartly invest in different parts of the business,” a recent article quotes Correlate Energy President and CEO Todd Michaels as saying. “Solar is the most applicable tech right now. It’s beating the grid for cost. You can…

WednesdayMay 08, 2024 3:00 pm

QualityStocksNewsBreaks – DeFi Technologies Inc.’s (CBOE CA: DEFI) (GR: R9B) (OTCQB: DEFTF) Subsidiary Valour Inc. Positioned to Capitalize on Opportunities in Digital Assets Space

DeFi Technologies (CBOE CA: DEFI) (GR: R9B) (OTCQB: DEFTF), a financial technology company that pioneers the convergence of traditional capital markets with the world of decentralized finance (“DeFi”), has announced that its subsidiary Valour Inc., a leading issuer of exchange traded products (“ETPs”) that provide simplified access to digital assets, has successfully repaid US$19.5 million in outstanding loans. According to the announcement, as of April 30, 2024, Valour has fully repaid balances of US$6 million and US$13.5 million, which were secured by BTC and ETH collateral, respectively. No further equity or debt was raised to repay the loans. The announcement…

WednesdayMay 08, 2024 2:11 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Dosing of Human Pilot Study No. 2, GLP-1-H24-2

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its second human pilot study, GLP-1-H24-2, is underway and the first dosing visit for all nine study participants has concluded. The three-arm, crossover study will compare three 7 mg semaglutide dose formulations: A positive control Rybelsus(R) swallowed tablet (already dosed); DehydraTECH-semaglutide swallowed capsules; and, for the first time ever, an in-mouth dissolvable DehydraTECH-semaglutide oral tablet. According to the announcement, the second DehydraTECH study arm will use a Rybelsus(R) composition processed with DehydraTECH that is compliant with the U.S. Food and Drug Administration’s Inactive Ingredient Database…

WednesdayMay 08, 2024 2:04 pm

QualityStocksNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Schedules Release of Q1 2024 Financial Results, Conference Call

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, IoT and cybersecurity sectors, will hold a conference call at 10 a.m. Eastern Time on Wednesday, May 15, 2024, to discuss its financial results for the first quarter ended March 31, 2024. According to the announcement, financial results will be issued in a press release prior to the call. Interested parties should visit https://ibn.fm/ZsII0 to register for the event and dial 888-506-0062 (U.S. toll-free), 1-809-423-853 (Israel toll-free) or 973-528-0011 (international) and state SuperCom as the access code to join the call. Attendees are asked to join via the…

WednesdayMay 08, 2024 12:55 pm

QualityStocksNewsBreaks – Why Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) Is ‘One to Watch’

Tartisan Nickel (CSE: TN) (OTCQB: TTSRF) is a Canadian mineral and battery metals exploration and mining development company. The company’s Kenbridge Nickel Project, located in the Kenora Mining District in the Province of Ontario, is an advanced-staged nickel deposit with a measured, indicated and inferred resource that has an existing 622-meter three compartment shaft. “As the world looks to utilize electric vehicles (‘EVs’) in an effort to reduce air pollution, demand for EV battery metals is on the rise,” a recent article reads. “Nickel is one of these in-demand battery metals, and there are few new, high grade development projects…

TuesdayMay 07, 2024 2:12 pm

QualityStocksNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Announces Publication of Article on Emerging Candidate – Sigyn Therapy(TM)

Sigyn Therapeutics (OTCQB: SIGY), a development-stage medical technology company, today announced that it has published an article entitled: “Sigyn Therapy(TM), an Emerging Candidate to Address Endotoxemia, Sepsis and Drug-Resistant Viral & Bacterial Infections.” “When we designed Sigyn Therapy, we envisioned a medical device that could overcome the limitations of previous blood purification technologies to treat life-threatening conditions that are beyond the reach of drugs. Along with the efforts of our dedicated team, contributions from science advisors, collaborators and shareholders have helped to advance our vision toward reality,” said Jim Joyce, co-founder and CEO of Sigyn Therapeutics. “Consider that in the…

TuesdayMay 07, 2024 2:04 pm

QualityStocksNewsBreaks – GEMXX Corporation (GEMZ) Announces Expansion Efforts, Appoints New Board Member

GEMXX (OTC: GEMZ), a leading provider of exquisite gemstone jewelry, is expanding its business model to include private equity funding for oil and gas (“O&G”) exploration. According to the announcement, the company is leveraging already-established relationships around the world as well as newly formed strategic partnerships to create a new business channel designed to fund exploration of giant (500 million barrels) and super-giant (3 billion+ barrels) oil fields located in Latin America. This strategic decision allows the company to “tap into moderate-risk, high-reward onshore O&G opportunities,” the announcement noted. GEMXX will be focused on overlooked and underexplored basins. As part…

MondayMay 06, 2024 3:32 pm

QualityStocksNewsBreaks – Cemtrex Inc. (NASDAQ: CETX) Closes on Upsized Underwritten Public Offering Worth $10M

Cemtrex (NASDAQ: CETX), an advanced-security technology and industrial services company, has closed on a firm-commitment underwritten public offering. According to the announcement, the company will receive an estimated $10 million in gross proceeds from the offering, before standard deductions and expenses. Upsized from an original $9 million commitment, the base offering consisted of 11,764,705 common units or prefunded units; the purchase price of each common unit was $0.85, and the purchase price of each prefunded unit was $0.849. Cemtrex anticipates using the net proceeds from the offering for operations as well as to increase marketing efforts and invest in existing…

Site Search

Company Search

Category: QualityStocksNewsBreaks